Evidence map›Paper›PMID 30726695›Full record

ReviewThe New England journal of medicine2019

Organoids - Preclinical Models of Human Disease.

Mo Li, Juan C Izpisua Belmonte

6 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in The New England journal of medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 202 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04342286 completednot on this mapstarted 2020, after this paper: background citation

To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer

TypeobservationalSponsorChinese University of Hong KongRan2020 to 2021Enrolled20ConditionsKidney CancerArmsOrganoid culture
NCT06077591 narecruitingnot on this mapstarted 2024, after this paper: background citation

Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors

TypeinterventionalSponsorChinese University of Hong KongRan2024 to 2028Enrolled40ConditionsHepatocellular Carcinoma, Colorectal CancerArmsPatient-Derived Tumor Organoids
NCT06246630 naunknown statusnot on this mapstarted 2024, after this paper: background citation

A Prospective, Exploratory Study Evaluating the Effectiveness of Treatment Regimens for Locally Advanced/Metastatic Non-resectable Pancreatic Neuroendocrine Tumor (PNET) Guided by in Vitro Drug Sensitivity Testing of Tumor Organoids

TypeinterventionalSponsorRuijin HospitalRan2024 to 2026Enrolled20ConditionsAdvanced Pancreatic Neuroendocrine TumorArmsChemotherapy and targeted-therapy guided by organoid drug sensitivity test
NCT06406608 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

TypeinterventionalSponsorHenan Cancer HospitalRan2024 to 2026Enrolled20ConditionsNon-small Cell Lung CancerArmsChemotherapy and targeted-therapy guided by organoid drug sensitivity test
NCT06406660 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

TypeinterventionalSponsorHenan Cancer HospitalRan2024 to 2026Enrolled20ConditionsSmall Cell Lung CancerArmsChemotherapy and targeted-therapy guided by organoid drug sensitivity test
NCT06438055 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

TypeinterventionalSponsorTianjin Medical University Cancer Institute and HospitalRan2024 to 2026Enrolled40ConditionsRefractory Breast CancerArmsChemotherapy and targeted-therapy guided by organoid drug sensitivity test
3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Media portrayal of ethical and social issues in brain organoid research.Philosophy, ethics, and humanities in medicine : PEHM · 2022
    Pooled it
  4. Pooled it
  5. Article
  6. Injury and therapy in a human spinal cord organoid.Nature biomedical engineering · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Development-based In Vivo Bioreactor Strategy for Challenging Senescent Bone Reconstruction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mo LiFrom the King Abdullah University of Science and Technology, Thuwal, Saudi Arabia (M.L.); and the Salk Institute for Biological Studies, La Jolla, CA (J.C.I.B.).
Juan C Izpisua BelmonteFrom the King Abdullah University of Science and Technology, Thuwal, Saudi Arabia (M.L.); and the Salk Institute for Biological Studies, La Jolla, CA (J.C.I.B.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Models, BiologicalOrganoidsAdult Stem CellsAnimalsBiomedical ResearchCell Culture TechniquesDisease Models, AnimalDrug DiscoveryHumansPluripotent Stem Cells

Identifiers

PMID30726695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.